An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications. Compounded pharmaceutical dosage forms may be ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...

The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...

Eli Lilly said copycat versions of Zepbound that add B12 result in potentially dangerous impurities. The compounding industry ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

Wilmington, Delaware, United States, Transparency Market Research Inc. –, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The global compounding pharmacy market (복합 약국 시장) was valued at US$ 13,474.6 Million in 2023 ...

When approved drugs do not exist for a species, condition or delivery route, compounded medications can fill the gap. These formulations provide new flexibility for managing livestock health.

Sometimes the needs of a patient are so unique that prescription medications readily available at retail drug stores are not sufficient to combat the illness or treat the condition. An example of such ...

A year ago, the FDA took the unusual step of inserting itself into the controversy over the KV Pharmaceutical drug known as Makena, which the agency had approved for premature births under the Orphan ...